Biomarkers in Parkinson disease: It's time to combine.
Identifieur interne : 000479 ( PubMed/Curation ); précédent : 000478; suivant : 000480Biomarkers in Parkinson disease: It's time to combine.
Auteurs : Martin J. Mckeown [États-Unis] ; Guerry M. Peavy [États-Unis]Source :
- Neurology [ 1526-632X ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , cerebrospinal fluid : Amyloid beta-Peptides, Peptide Fragments, alpha-Synuclein.
- physiopathology : Brain, Parkinson Disease.
- Female, Humans, Male.
DOI: 10.1212/WNL.0000000000001692
PubMed: 25979702
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000479
Links to Exploration step
pubmed:25979702Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Biomarkers in Parkinson disease: It's time to combine.</title><author><name sortKey="Mckeown, Martin J" sort="Mckeown, Martin J" uniqKey="Mckeown M" first="Martin J" last="Mckeown">Martin J. Mckeown</name><affiliation wicri:level="3"><nlm:affiliation>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego. martin.mckeown@ubc.ca.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">San Diego</settlement><region type="state">Californie</region></placeName><wicri:orgArea>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California</wicri:orgArea></affiliation></author><author><name sortKey="Peavy, Guerry M" sort="Peavy, Guerry M" uniqKey="Peavy G" first="Guerry M" last="Peavy">Guerry M. Peavy</name><affiliation wicri:level="3"><nlm:affiliation>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">San Diego</settlement><region type="state">Californie</region></placeName><wicri:orgArea>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California</wicri:orgArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25979702</idno><idno type="pmid">25979702</idno><idno type="doi">10.1212/WNL.0000000000001692</idno><idno type="wicri:Area/PubMed/Corpus">000479</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000479</idno><idno type="wicri:Area/PubMed/Curation">000479</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000479</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Biomarkers in Parkinson disease: It's time to combine.</title><author><name sortKey="Mckeown, Martin J" sort="Mckeown, Martin J" uniqKey="Mckeown M" first="Martin J" last="Mckeown">Martin J. Mckeown</name><affiliation wicri:level="3"><nlm:affiliation>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego. martin.mckeown@ubc.ca.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">San Diego</settlement><region type="state">Californie</region></placeName><wicri:orgArea>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California</wicri:orgArea></affiliation></author><author><name sortKey="Peavy, Guerry M" sort="Peavy, Guerry M" uniqKey="Peavy G" first="Guerry M" last="Peavy">Guerry M. Peavy</name><affiliation wicri:level="3"><nlm:affiliation>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">San Diego</settlement><region type="state">Californie</region></placeName><wicri:orgArea>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California</wicri:orgArea></affiliation></author></analytic><series><title level="j">Neurology</title><idno type="eISSN">1526-632X</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amyloid beta-Peptides (cerebrospinal fluid)</term><term>Brain (physiopathology)</term><term>Female</term><term>Humans</term><term>Male</term><term>Parkinson Disease (physiopathology)</term><term>Peptide Fragments (cerebrospinal fluid)</term><term>alpha-Synuclein (cerebrospinal fluid)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="cerebrospinal fluid" xml:lang="en"><term>Amyloid beta-Peptides</term><term>Peptide Fragments</term><term>alpha-Synuclein</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25979702</PMID><DateCreated><Year>2015</Year><Month>06</Month><Day>16</Day></DateCreated><DateCompleted><Year>2015</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>24</Issue><PubDate><Year>2015</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Biomarkers in Parkinson disease: It's time to combine.</ArticleTitle><Pagination><MedlinePgn>2392-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000001692</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McKeown</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego. martin.mckeown@ubc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peavy</LastName><ForeName>Guerry M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Neurology. 2015 Jun 16;84(24):2413-21</RefSource><PMID Version="1">25979701</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25979702</ArticleId><ArticleId IdType="pii">WNL.0000000000001692</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000001692</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000479 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000479 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25979702
|texte= Biomarkers in Parkinson disease: It's time to combine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25979702" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |